Marshall Wace, LLP ENLIVEN THERAPEU Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024
Number of Shares
138,006
Previous 192,100 28.16%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
N/A
-54,094 Reduced 28.16%
138,006 $0
Q2 2024

Aug 14, 2024
BUY
N/A
192,100 New
192,100 $0
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email